E-Pharmacophore Based Virtual Screening to Identify Agonist for PKA-Cñ

Owing to PKA-Cα unique functions in regulating tau splicing alternatively in neurons results in aggregation of tau which contributes to neurofibrillary tangles and taupathies generation a hallmark of Alzheimer’s disease (AD). PKACα also inhibits GSK3β thus it has been a therapeutic target for AD intervention. In this study, e-pharmacophore and multiple docking strategies were followed to propose a novel PKA-Cα agonists. Nine e-pharmacophores were developed from nine co-crystal structures such that all the critical pharmacophoric features involved in their bioactivity of PKA-Cα were effectively mapped. Rigid receptor docking (RRD) was performed with the library of PKA-Cα activators having 3512 shape screened compounds towards PKA-Cα. To derive the best leads, dock complexes were further subjected to QPLD, IFD and MM-GBSA calculations. PKA-Cα-lead1 dock complex was subjected to 50 ns MD simulations run. Comparative analysis between obtained 25 leads and 9 co-crystal ligands revealed three the best leads. Among the three, lead1 has the least docking score with lowest binding free energy with better binding orientation towards PKA-Cα. The constancy of PKA-Cα-lead1 interactions was revealed by 50 ns MD simulations run. Thus ADME predictions and results from RRD, QPLD, IFD and MD simulations affirmed that the proposed three leads might be used as a potent agonists for PKA-Cα.

[1]  David Calkins,et al.  Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution , 2010, J. Comput. Aided Mol. Des..

[2]  David W. Ritchie,et al.  Discovery of Novel HIV Entry Inhibitors for the CXCR4 Receptor by Prospective Virtual Screening , 2009, J. Chem. Inf. Model..

[3]  G Forster,et al.  Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. , 2009, Brain : a journal of neurology.

[4]  Philip M. Dean,et al.  Hydration in drug design. 1. Multiple hydrogen-bonding features of water molecules in mediating protein-ligand interactions , 1995, J. Comput. Aided Mol. Des..

[5]  Caterina Barillari,et al.  Classification of water molecules in protein binding sites. , 2007, Journal of the American Chemical Society.

[6]  Karel Berka,et al.  PDBsum additions , 2013, Nucleic Acids Res..

[7]  A. Hopkins,et al.  Navigating chemical space for biology and medicine , 2004, Nature.

[8]  D. Dickson,et al.  Differential incorporation of tau isoforms in Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.

[9]  Yasushi Tojo,et al.  Prediction of Potency of Protease Inhibitors Using Free Energy Simulations with Polarizable Quantum Mechanics‐Based Ligand Charges and a Hybrid Water Model. , 2010 .

[10]  M. Munikumar,et al.  197 Combination of e-pharmacophore modeling, multiple docking strategies and molecular dynamic simulations to discover of novel antagonists of BACE1 , 2015, Journal of biomolecular structure & dynamics.

[11]  P. Yogeeswari,et al.  Multiple e‐Pharmacophore Modeling Combined with High‐Throughput Virtual Screening and Docking to Identify Potential Inhibitors of β‐Secretase(BACE1) , 2013, Molecular Informatics.

[12]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[13]  V. Madison,et al.  Induced-fit docking of mometasone furoate and further evidence for glucocorticoid receptor 17alpha pocket flexibility. , 2008, Journal of molecular graphics & modelling.

[14]  Dibyabhaba Pradhan,et al.  Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study , 2014, Journal of biomolecular structure & dynamics.

[15]  R. Dror,et al.  Microsecond molecular dynamics simulation shows effect of slow loop dynamics on backbone amide order parameters of proteins. , 2008, The journal of physical chemistry. B.

[16]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[17]  Georgios Archontis,et al.  Kinetics, in silico docking, molecular dynamics, and MM‐GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP‐binding site inhibitors: The role of water molecules examined , 2011, Proteins.

[18]  K. Sivaprakasam.  Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation. , 2006, Current medicinal chemistry.

[19]  Kai Zhu,et al.  Structure-Based Virtual Screening Approach for Discovery of Covalently Bound Ligands , 2014, J. Chem. Inf. Model..

[20]  Lazaros Mavridis,et al.  Comprehensive Comparison of Ligand-Based Virtual Screening Tools Against the DUD Data set Reveals Limitations of Current 3D Methods , 2010, J. Chem. Inf. Model..

[21]  Christopher I. Bayly,et al.  Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem , 2007, J. Chem. Inf. Model..

[22]  Chao-Yie Yang,et al.  Importance of ligand reorganization free energy in protein-ligand binding-affinity prediction. , 2009, Journal of the American Chemical Society.

[23]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[24]  Victor Guallar,et al.  Importance of accurate charges in molecular docking: Quantum mechanical/molecular mechanical (QM/MM) approach , 2005, J. Comput. Chem..

[25]  Christopher R Sweet,et al.  The canonical ensemble via symplectic integrators using Nosé and Nosé-Poincaré chains. , 2004, The Journal of chemical physics.

[26]  Art E. Cho,et al.  Extension of QM/MM docking and its applications to metalloproteins , 2009, J. Comput. Chem..

[27]  R. Friesner,et al.  Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .

[28]  Santiago Vilar,et al.  In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor. , 2011, Journal of molecular graphics & modelling.

[29]  Jianhua Shi,et al.  PKA modulates GSK‐3β‐ and cdk5‐catalyzed phosphorylation of tau in site‐ and kinase‐specific manners , 2006, FEBS letters.

[30]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[31]  Antonio Carrieri,et al.  Biological Profiling of Anti‐HIV Agents and Insight into CCR5 Antagonist Binding Using in silico Techniques , 2009, ChemMedChem.

[32]  Eric T. Kim,et al.  How does a drug molecule find its target binding site? , 2011, Journal of the American Chemical Society.

[33]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[34]  Jeremy R. Greenwood,et al.  Epik: a software program for pKa prediction and protonation state generation for drug-like molecules , 2007, J. Comput. Aided Mol. Des..

[35]  Dibyabhaba Pradhan,et al.  Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis , 2014, Journal of biomolecular structure & dynamics.

[36]  Kenyon G. Daniel,et al.  Computational Validation of the Importance of Absolute Stereochemistry in Virtual Screening , 2008, J. Chem. Inf. Model..

[37]  Paul D Lyne,et al.  Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. , 2006, Journal of medicinal chemistry.

[38]  Simona Distinto,et al.  How To Optimize Shape-Based Virtual Screening: Choosing the Right Query and Including Chemical Information , 2009, J. Chem. Inf. Model..

[39]  V. Tan,et al.  Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3′-oxime from molecular dynamics simulations , 2006, Journal of molecular modeling.